LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the …
Over the last 12 months, insiders at LeMaitre Vascular, Inc. have bought $0 and sold $41.35M worth of LeMaitre Vascular, Inc. stock.
On average, over the past 5 years, insiders at LeMaitre Vascular, Inc. have bought $209,078 and sold $24.7M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 30 shares for transaction amount of $932 was made by Roush John A (director) on 2020‑08‑26.
2024-08-13 | Sale | President and Director | 3,063 0.0137% | $82.07 | $251,380 | 0.00% | ||
2024-08-05 | Sale | Senior V. P., Operations | 182 0.0008% | $81.82 | $14,891 | +11.46% | ||
2024-07-16 | Sale | Chairman and CEO | 57,372 0.2706% | $86.69 | $4.97M | +2.10% | ||
2024-07-15 | Sale | Chairman and CEO | 27,030 0.1269% | $86.27 | $2.33M | 0.00% | ||
2024-07-12 | Sale | Chairman and CEO | 12,976 0.0608% | $86.07 | $1.12M | 0.00% | ||
2024-05-16 | Sale | director | 5,500 0.0244% | $77.99 | $428,945 | +11.48% | ||
2024-05-14 | Sale | Chairman and CEO | 40,968 0.1805% | $76.80 | $3.15M | +10.89% | ||
2024-05-13 | Sale | Chairman and CEO | 35,826 0.1608% | $76.42 | $2.74M | +13.40% | ||
2024-05-08 | Sale | Chairman and CEO | 8,000 0.036% | $75.30 | $602,427 | +15.05% | ||
2024-05-07 | Sale | Chairman and CEO | 26,044 0.117% | $75.24 | $1.96M | +13.76% | ||
2024-05-07 | Sale | Chairman and CEO | 46,300 0.2087% | $75.51 | $3.5M | +13.76% | ||
2024-05-06 | Sale | Chairman and CEO | 68,906 0.3113% | $75.70 | $5.22M | +14.99% | ||
2024-05-06 | Sale | President and Director | 5,025 0.0227% | $75.62 | $379,991 | +14.99% | ||
2024-03-08 | Sale | Senior V. P., Operations | 4,542 0.0205% | $68.18 | $309,684 | +19.48% | ||
2024-03-07 | Sale | director | 7,500 0.0339% | $69.00 | $517,500 | +16.91% | ||
2024-03-05 | Sale | director | 5,110 0.0229% | $67.50 | $344,925 | +18.90% | ||
2024-03-04 | Sale | Chairman and CEO | 36,600 0.1643% | $68.03 | $2.49M | +18.01% | ||
2024-03-01 | Sale | Chairman and CEO | 37,019 0.1667% | $67.85 | $2.51M | +18.57% | ||
2024-02-29 | Sale | Chairman and CEO | 27,859 0.1248% | $69.73 | $1.94M | +14.37% | ||
2024-02-29 | Sale | Chief Financial Officer | 36,967 0.1657% | $69.77 | $2.58M | +14.37% |
LeMaitre George W | Chairman and CEO | 1900956 8.4604% | $101.84 | 17 | 200 | +14.05% |
Roberts David B | President and Director | 14114 0.0628% | $101.84 | 1 | 81 | +68.49% |
Pellegrino Joseph P JR | Chief Financial Officer | 6452 0.0287% | $101.84 | 1 | 40 | |
Roush John A | director | 2278 0.0101% | $101.84 | 2 | 6 | +51.72% |
LeMaitre Cornelia W | director | 178319 0.7936% | $101.84 | 3 | 106 | <0.0001% |
BlackRock | $222.56M | 14.94 | 3.35M | +1.72% | +$3.75M | 0.01 | |
Conestoga Capital Advisors, LLC | $128.27M | 8.61 | 1.93M | +0.26% | +$328,216.54 | 1.89 | |
The Vanguard Group | $103.11M | 6.92 | 1.55M | +0.32% | +$329,411.04 | <0.01 | |
Copeland Capital Management LLC | $85.66M | 5.75 | 1.29M | +2.46% | +$2.05M | 1.56 | |
Geneva Capital Management LLC | $59.73M | 4.01 | 900,038 | -0.52% | -$310,963.03 | 1.05 |